AdvertisementAstraZeneca has agreed to acquire Icosavax, Inc., a US-based clinical-stage biopharmaceutical company focused on developing differentiated, high-potential vaccines using an innovative, protein virus-like particle (VLP) platform. The deal is valued … Continue reading AstraZeneca to acquire clinical-stage respiratory vaccine company